Clinical case of the development and course of Graves' disease against the background of HIV and HCV-infection

2024

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.59598/me-2305-6045-2024-110-1-70-76
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

This article discusses a clinical case of the onset and course of Graves' disease against the background of long-term antiretroviral therapy, interferons. The complexity of this case was the resistance of thyrotoxicosis therapy, as well as the impossibility of prescribing the necessary doses to normalize the thyroid profile due to the drug's hepatotoxicity. During the treatment of thyrotoxicosis, an increase in liver enzymes occurred. The tactic was adopted to perform a thyroidectomy with sedation. After normalization of liver function for a period of 2 months, it was possible to achieve subcompensated thyrotoxicosis by taking Tyrozol 40 mg per day. After the strumectomy, the patient’s condition was much better. Started hormone replacement therapy, thyroid status returned to normal. It was concluded that it is necessary to exclude the development of thyrotoxicosis by determining the level of TSH, the levels of free thyroxine and triiodothyronine, the determination of antibodies to thyroperoxidase, antibodies to the TSH receptor before starting antiretroviral therapy and interferon therapy.